期刊文献+

充分发挥临床药师的作用 确保肿瘤患者用药安全 被引量:9

Give Full Play to the Role of Clinical Pharmacists to Ensure Medication Safety in Patients with Cancer
下载PDF
导出
摘要 目的探讨抗肿瘤药物临床药师在肿瘤患者实施化疗中的作用。方法从临床药师化疗前协助医生制定化疗方案,做好化疗前预处理;化疗时加强与护士沟通,关注用药细节;化疗后加强与患者的沟通,提高依从性等方面,探讨抗肿瘤临床药师的作用。结果临床药师的参与有效提高了药物疗效,增强了患者的依从性,降低了药物不良反应的发生率。结论临床药师只有强化药学知识,加强与医、护、患之间的有效沟通,才能确保肿瘤患者用药安全。 Objective To explore the clinical pharmacists of antineoplastic chemotherapy in cancer patients the role of the implementation.Methods Discuss the role of antineoplastic clinical pharmacists from the aspects which clinical pharmacists assist physicians by developing chemotherapy regimen and good pretreatment before chemotherapy;Enhance communication with the nurse and concern about the drug details at chemotherapy;Enhance communication with patients and improve compliance after chemotherapy.Results The participation of clinical pharmacists improve drug efficacy,increase patient compliance and reduce the incidence of adverse drug reactions.Conclusion Only by strengthening pharmaceutical knowledge and enhancing effective communication with physicians,nurses and patients,can the clinical pharmacist ensure the drug safety of cancer cure.
出处 《中国药事》 CAS 2012年第2期203-205,共3页 Chinese Pharmaceutical Affairs
关键词 抗肿瘤药 临床药师 沟通 antineoplastic clinical pharmacist communicate
  • 相关文献

参考文献9

二级参考文献42

  • 1张文,许立功.晚期结直肠癌的化疗进展[J].中国癌症杂志,2004,14(4):378-382. 被引量:25
  • 2杨翠荣 王玉环 王霞.环丙沙星与氨苄青霉素同时应用时应注意的问题[J].实用护理杂志,2001,17(3):43-43.
  • 3Cancer Therapy Evaluation Program, Common terminology criteria for adverse events Version 3.0, DCTD, NCI, NIH. , 2003 [ EB/ OL]. [2008 - 12 - 10]. http://ctep, cancer, gov.
  • 4RANSON M, HAMMOND LA, FERRY D, et al. ZD1839, a seective oral epidermal growth factor receptortyrosine kinase inhibi tot, is well tolerated and active in patients with solid, malignan// tumors : results of a phase Ⅰ trial[ J ]. J Clin Oncol,2002,20 ( 9 ) 2240 - 2250.
  • 5HIDALGO M, SIU LL, NEMUNAITIS J ,et al. Phase Ⅰ and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies[ J]. J Clin Oncol,2001,19 ( 13 ) :3267 - 3279.
  • 6JACOT W, BESSIS D, JORDA E, et al. Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours[ J]. Br J Dermatol,2004,151 ( 1 ) :238 -241.
  • 7PEREZ-SOLER R, CHACHOUA A, HAMMOND LA,et al. Determinants of tumor response and survival with erlotinib in patients with none small-cell lung cancer[J]. J Clin Oncol, 2004, 22 ( 16 ) :3238 - 3247.
  • 8VAN DOORN R, KIRTSCHIG G, SCHEFFER E,et al. Follicular and epidermal alterations in patients treated with ZD1839 (lressa), an inhibitor of the epidermal growth factor receptor [ J ]. Br J Dermatol,2002, 147 ( 3 ) : 598 - 601.
  • 9SHAH NT, KRIS MG, PAO W, et al. Practical management of patients with non-small-cell lung cancer treated with gefitinib [ J ]. J Clin Oncol,2005,23 (1) : 165 - 174.
  • 10CLARK JW, EDER JP, RYAND. et al. Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced refractory solid tumors [ J ]. Clin Cancer Res, 2005, 11 ( 15 ) :5472 - 5480.

共引文献85

同被引文献100

  • 1谭永红,曾仁杰,王诗华,段艳冰,梁蓉梅.临床药师应重视肿瘤患者的药疗监护[J].中国药房,2004,15(12):763-764. 被引量:18
  • 2刘洋,高文桂,刘伟平.顺铂注射液光稳定性研究[J].中国药事,2005,19(10):613-614. 被引量:26
  • 3卫生部.医院处方点评管理规范(试行)[S]卫医管发[2010]28号.,..
  • 4孙燕,周际昌.临床肿瘤内科手册[M].第4版.北京:人民卫生出版社,2004.102-104,107-113.
  • 5魏群利,吴云明.时辰药理学与时辰治疗学[M].北京:人民军医出版社,2011:90.
  • 6Matarese L E, Steiger E, Seidner D L, et aI. Body compo- sition changes in cachectic patients receiving home parenteraI nutritio [J]. JPEN, 2002, 26 (6): 366-367.
  • 7August DA, Huhmann MB. A. S. P. E. N. Clinical Guidelines.. Nutrition Support Therapy During Adult Anticancer Treatment and in Hematopoietic Cell Transplantation [J]. JPEN , 2009, 33 (4): 472 500.
  • 8Pacelli F, Bossola M, Teodori L, et al. Parenteral nutri- tion does not stimulate tumor proliferation in malnourished gastric cancer patients [J]. JPEN J Parenter Enteral Nutr, 2007, 31 (6): 451-453.
  • 9卫生部.国家中医药管理局.处方管理办法[S].卫生部令第53号.
  • 10Garlipp B, Sehwalenberg J, Adolf D, et al. Epidemiology, surgical management and early postoperative outcome in a cohort of gastric cancer patients of a tertiaT'y referral center in relation to multi-cen- ter quality assurance studies [ J ]. Pol Przegl Clair, 2011,83 ( 3 ) : 123 - 134.

引证文献9

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部